Saratin for inhibiting platelet adhesion to collagen
CA 2419385 C · Owner: Barnes, Christopher · Inventors: Strittmatter, Wolfgang; Hofmann, Uwe; Gleitz, Johannes
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Use of the polypeptide Saratin for the manufacture of a medicament having the capability to significantly decrease platelet adhesion and platelet accumulation after vascular injuries or endarterectomy. The invention furthermore relates to a novel medical use of Saratin as an inhibitor of thrombosis and intimal hyperplasia, wherein said polypeptide may be used locally as a topical agent or as a coating on or otherwise incorporated or , associated with medical devices.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed August 23, 2001 and granted May 10, 2011. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended August 23, 2021.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by August 23, 2023.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.